Philogen S.p.A.

16/07/2024 | Press release | Distributed by Public on 17/07/2024 02:52

Philogen to attend the EFMC ISMC 2024 on September 4, 2024 in Rome

Yu Ding, male, was born in April 1978. He is currently a Professor in School of Life Sciences, Fudan University. Dr. Ding attended the Science Base Class at the School of Life Sciences, Fudan University, from 1996 to 1999, obtaining a bachelor's degree. He pursued Biophysics at the School of Life Sciences, Fudan University, from 1999 to 2004, earning a Ph.D. degree. Dr. Ding was appointed as a lecturer in 2004, promoted to associate professor in 2007, and to professor in 2020. From February 2009 to September 2011, he participated in an exchange program at the Department of Chemistry, the University of Hong Kong. His research interest focused on Autophagy-Lysosome-Based Pathogenic Macromolecular Targeted Degradation Technology (ATTEC) and Nanobody Technology. Selected Publications: Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds, Z Li, C Wang, Z Wang, C Zhu, J Li, T Sha, L Ma, C Gao…, Y Ding#, Y Fei#, B Lu#, Nature, 575(7781): 203, (2019) (Selected as one of Nature's Top 10 Outstanding Papers of 2019) Emerging degrader technologies engaging lysosomal pathways, Y Ding#, D Xing#, Y Fei#, B Lu#, Chemical Society Reviews, 51:8832, (2022) (Cover article) Degradation of lipid droplets by chimeric autophagy-tethering compounds, Y Fu, N Chen, Z Wang, S Luo, Y Ding#, B Lu#, Cell research, 31(9): 965, (2021) (Cover article, recipient of the Sanofi-Cell Research 2021 Outstanding Paper Award)